bpc 157 intervertebral disc regeneration: do nutrients lead the way? Physical disruption of intervertebral disc
Description
As of a January 2026 legal analysis, BPC-157 remained listed in Category 2, and the compound cannot legally be compounded under sections 503A or 503B of the Food, Drug and Cosmetic Act
it signals local repair processes
BPC-157 has no human dose-finding trials, so doses come from animal studies and documented practice [1][2]
Its often recommended for people who have trouble converting Cyanocobalamin into its active form
